Naropin (ropivacaine): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1564492295

Medication indications

Naropin 10 mg/ml solution for injection

Naropin 7.5 mg/ml is indicated in adults and adolescents aged above 12 years of age for:

Surgical anaesthesia:

- Epidural blocks for surgery, including Caesarean section.

- Major nerve blocks.

- Field blocks.

Naropin 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for:

Surgical anaesthesia:

- Epidural blocks for surgery.

Naropin 2 mg/ml is indicated for acute pain management

In adults and adolescents above 12 years of age for:

- Continuous epidural infusion or intermittent bolus administration during postoperative or labour pain.

- Field blocks.

- Continuous peripheral nerve block via a continuous infusion or intermittent bolus injections, e.g. postoperative pain management.

In infants from 1 year and children up to and including 12 years of age (per- and postoperative):

- Single and continuous peripheral nerve block.

In neonates, infants and children up to and including 12 years of age for (per- and postoperative):

- Caudal epidural block.

- Continuous epidural infusion.

Naropin 2 mg/ml solution for infusion

Naropin 7.5 mg/ml is indicated in adults and adolescents aged above 12 years of age for:

Surgical anaesthesia:

- Epidural blocks for surgery, including Caesarean section.

- Major nerve blocks.

- Field blocks.

Naropin 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for:

Surgical anaesthesia:

- Epidural blocks for surgery.

Naropin 2 mg/ml is indicated for acute pain management

In adults and adolescents above 12 years of age for:

- Continuous epidural infusion or intermittent bolus administration during postoperative or labour pain.

- Field blocks.

- Continuous peripheral nerve block via a continuous infusion or intermittent bolus injections, e.g. postoperative pain management.

In infants from 1 year and children up to and including 12 years of age (per- and postoperative):

- Single and continuous peripheral nerve block.

In neonates, infants and children up to and including 12 years of age for (per- and postoperative):

- Caudal epidural block.

- Continuous epidural infusion.

Naropin 2 mg/ml solution for injection

Naropin 7.5 mg/ml is indicated in adults and adolescents aged above 12 years of age for:

Surgical anaesthesia:

- Epidural blocks for surgery, including Caesarean section.

- Major nerve blocks.

- Field blocks.

Naropin 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for:

Surgical anaesthesia:

- Epidural blocks for surgery.

Naropin 2 mg/ml is indicated for acute pain management

In adults and adolescents above 12 years of age for:

- Continuous epidural infusion or intermittent bolus administration during postoperative or labour pain.

- Field blocks.

- Continuous peripheral nerve block via a continuous infusion or intermittent bolus injections, e.g. postoperative pain management.

In infants from 1 year and children up to and including 12 years of age (per- and postoperative):

- Single and continuous peripheral nerve block.

In neonates, infants and children up to and including 12 years of age for (per- and postoperative):

- Caudal epidural block.

- Continuous epidural infusion.

Naropin 7.5 mg/ml solution for injection

Naropin 7.5 mg/ml is indicated in adults and adolescents aged above 12 years of age for:

Surgical anaesthesia:

- Epidural blocks for surgery, including Caesarean section.

- Major nerve blocks.

- Field blocks.

Naropin 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for:

Surgical anaesthesia:

- Epidural blocks for surgery.

Naropin 2 mg/ml is indicated for acute pain management

In adults and adolescents above 12 years of age for:

- Continuous epidural infusion or intermittent bolus administration during postoperative or labour pain.

- Field blocks.

- Continuous peripheral nerve block via a continuous infusion or intermittent bolus injections, e.g. postoperative pain management.

In infants from 1 year and children up to and including 12 years of age (per- and postoperative):

- Single and continuous peripheral nerve block.

In neonates, infants and children up to and including 12 years of age for (per- and postoperative):

- Caudal epidural block.

- Continuous epidural infusion.


Route of administration: Injectable
Molecule: ropivacaine

Patients' opinions on Naropin

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.